Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02232269Phase 1Completed
Phase 1, randomised, open-label trial of felodipine in hypertension (HTN) (4 arms). Primary endpoint: Peripheral and Central Blood Pressure at 8 hours. Started Feb 2012; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02232269.